Edwards Lifesciences Corp (EW) 106.27 $EW Zacks Industry

New Post Public Reply Private Reply Replies (0) Message Board

Jul 13, 2016 at 4:13 AM

Edwards Lifesciences Corp (EW) 106.27 $EW

Zacks Industry Outlook Highlights: Edwards Lifesciences, Medtronic and Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 8:30AM CDT
Zacks Industry Outlook Highlights: Edwards Lifesciences, Medtronic and Johnson & Johnson
JNJ: 122.92 (-0.01), MDT: 88.92 (+0.41), EW: 106.27 (+1.79)

MedTech Industry Stock Outlook - July 2016
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:08PM CDT
MedTech Industry Stock Outlook - July 2016
JNJ: 122.92 (-0.01), MDT: 88.92 (+0.41), EW: 106.27 (+1.79)

SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 1.09% Gain
Comtex SmarTrend(R) - Tue Jul 05, 4:17PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $98.02 to a high of $100.20. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $99.83 on volume of 533,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 106.27 (+1.79)

Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors
PR Newswire - Tue Jul 05, 3:15PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Leslie S. Heisz has been appointed to its board of directors. Heisz has extensive experience in investment banking and finance, serving in executive-level roles at firms including Lazard Freres & Co., Wasserstein Perella & Co. and Salomon Brothers.
EW: 106.27 (+1.79)

Technical Coverage on Medical Appliances & Equipment Stocks - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Tue Jul 05, 7:00AM CDT
On Friday, July 01, 2016, the NASDAQ Composite ended the trading session at 4,862.57, up 0.41%; the Dow Jones Industrial Average edged 0.11% higher, to finish at 17,949.37; and the S&P 500 closed at 2,102.95, up 0.19%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Edwards Lifesciences Corporation (NYSE: EW), Stryker Corporation (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Learn more about these stocks by accessing their free trade alerts at:
ABMD: 117.76 (+1.82), EW: 106.27 (+1.79), ARAY: 5.37 (+0.07), SYK: 122.82 (+0.17)

How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 117.76 (+1.82), EW: 106.27 (+1.79), ARAY: 5.37 (+0.07), SYK: 122.82 (+0.17)

Luminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:04AM CDT
Luminex Corp (LMNX) recently announced the receipt of CE-IVD marking for the ARIES Flu A/B & RSV Assay.
MASI: 52.52 (+0.07), EW: 106.27 (+1.79), LMNX: 22.27 (+0.55), CRY: 12.20 (+0.01)

Look for Shares of Edwards Lifesciences to Potentially Rebound after Yesterday's 1.02% Sell Off
Comtex SmarTrend(R) - Tue May 31, 2:23PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $98.64 to a high of $100.66. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $98.97 on volume of 657,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 106.27 (+1.79)

Edwards Lifesciences To Present At Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 31, 1:51PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the Goldman Sachs 37th Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California on Tuesday, June 7, 2016.
EW: 106.27 (+1.79)

New Strong Buy Stocks for May 27th
Swarup Gupta - ZACKS - Fri May 27, 8:14AM CDT
New Strong Buy Stocks for May 27th
AMAT: 25.41 (+0.26), RESI: 9.15 (+0.10), EW: 106.27 (+1.79), KT: 14.66 (+0.19), TAST: 12.34 (-0.20)

Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:50AM CDT
Edwards Lifesciences (EW) made a strong start to 2016, with its first-quarter results beating estimates on both the fronts.
BSX: 23.64 (-0.13), SRDX: 24.87 (+0.08), BAX: 46.85 (+0.36), EW: 106.27 (+1.79)

S&P 500 to Celebrate One Year of New High: Top ETFs & Stocks
Sweta Killa - Zacks Investment Research - Fri May 20, 10:27AM CDT
We have highlighted five ETFs and stocks that have generated incredible returns over the past one-year period and have easily crushed the broader market.
REZ: 68.41 (-0.21), FB: 117.93 (+0.06), KBWP: 50.06 (unch), EW: 106.27 (+1.79), CPB: 66.47 (-0.24), TSN: 68.66 (+0.19), RHS: 129.08 (-0.81), PEY: 15.86 (+0.16), CVC: 34.87 (-0.01), PSCU: 49.65 (-0.01)

Baxter (BAX) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:22AM CDT
On May 20, Zacks Investment Research raised Baxter International Inc. (BAX) to a Zacks Rank #1 (Strong Buy).
SRDX: 24.87 (+0.08), MASI: 52.52 (+0.07), BAX: 46.85 (+0.36), EW: 106.27 (+1.79)

Quality Systems (QSII) Q4 Earnings Disappoint, Stock Falls
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:21AM CDT
Shares of Quality Systems Inc. (QSII) plunged almost 10% in after-hours trading following the company's disappointing fourth-quarter fiscal 2016 results.
SRDX: 24.87 (+0.08), MASI: 52.52 (+0.07), EW: 106.27 (+1.79), QSII: 12.81 (+0.21)

Jury Finds in Favor of CardiAQ in Case with Neovasc
PR Newswire - Thu May 19, 2:34PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced that a federal jury in Boston today returned a verdict in favor of CardiAQ in a lawsuit filed against a former service provider, Neovasc. The jury found that Neovasc breached the non-disclosure agreement between the parties, misappropriated CardiAQ's trade secrets, and breached its duty of honest performance to CardiAQ. The jury also awarded damages of $70 million for trade secret misappropriation.
EW: 106.27 (+1.79)

Masimo (MASI) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:16AM CDT
Shares of Masimo Corp (MASI) scaled a new 52-week high of $48.87 on May 18, eventually closing a tad bit lower at $48.51.
SRDX: 24.87 (+0.08), IRMD: 21.48 (-0.27), MASI: 52.52 (+0.07), EW: 106.27 (+1.79)

Strong Q4 for PetMed (PETS), New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:19AM CDT
On May 13, 2016, we issued an updated research report on PetMed Express (PETS).
SRDX: 24.87 (+0.08), MASI: 52.52 (+0.07), PETS: 19.33 (+0.04), EW: 106.27 (+1.79)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating AI Laws: A New Era for Privacy & Security

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Chemours Faces Investor Fraud Suit: Action Needed Now

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

CorePower Yoga Expands in Miami with New Studios

Greasing the Wheels of Miami's Wellness Scene If you're living under a rock, you might not have noticed, but CorePower Yoga is making some serious moves in Miami. We're talking about two new studios opening their doors: one in Midtown Miami, already rolling out the mats as of October 19, and another flagship joint soon to hit Coral Gables. Clearly, they see the demand for...

National Showrooms Expands into Virginia with Key Buy

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

PrePass Intelligence: A Game-Changer for Fleets

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

QFIN Faces Class Action: Investors' Role Explored

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Ford Foundation Welcomes Gender Justice Leader Fatima Goss Graves

A Fresh Addition to Ford's Trustees Fatima Goss Graves steps into big shoes at the Ford Foundation as she gets appointed to its Board of Trustees. No small potatoes, this move suggests the Foundation's commitment to driving significant gender justice and advocacy. Add her name next to serious change-makers, folks, because Ms. Goss Graves is a heavyweight in the nonprofit...

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Moore Law Urges Millrose Investors: Join the Action

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...